Eli Lilly Announces Major Investments in US Manufacturing

Pharmaceutical company Eli Lilly & Co. has announced plans to invest $2.7 billion to expand its manufacturing capabilities in the United States. This significant investment aims to strengthen the company's market position and expedite the delivery of essential medications to patients. The funds will be used to construct new manufacturing facilities, which will not only create jobs but also improve the accessibility of their products.

Continue reading